Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 45 Women only

Comparing daily and alternate day iron supplements for pregnant women with anemia

Official title: Oral Iron Supplementation on Alternate vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy

Run by Southern Illinois University · NCT06492512 · Data updated 2026-11-12

This study tests whether taking iron supplements every day or every other day helps pregnant women with anemia feel better and improve their iron levels.

More Pregnancy trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment120 (estimated)
SponsorSouthern Illinois University
Academic / other
Locations1 site (Springfield, Illinois)
StatusRecruiting
StartedMay 27, 2025
Main results expectedJuly 1, 2028
Study endsJuly 30, 2029
Registry record updatedApril 24, 2026
Trial IDNCT06492512 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant women under 30 weeks gestational age with laboratory-confirmed iron-deficiency anemia.

Probably not a fit

Patients with severe anemia requiring transfusions, other types of anemia, or certain gastrointestinal conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized clinical trial aims to evaluate the effectiveness of oral iron supplementation in pregnant women diagnosed with iron-deficiency anemia (IDA). Participants will be randomly assigned to receive either daily or alternate day doses of ferrous sulfate, each containing 65 mg of elemental iron. Blood tests will be conducted at the beginning to confirm iron deficiency, and all supplements will be provided by the study team to ensure consistency. The study will also control for other iron sources by providing identical prenatal vitamins to both groups.

Why it matters

Potential benefit: If successful, this study could optimize iron supplementation strategies for pregnant women, potentially improving maternal and fetal health outcomes.

How similar studies have gone: Previous studies have explored iron supplementation in pregnancy, but this specific comparison of dosing schedules is less common and may provide novel insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant patients will be enrolled at less than 30 weeks gestational age (GA) with laboratory confirmed IDA (as defined by hemoglobin under 10.5 g/dL, as well as ferritin under 15 mcg/L)

Exclusion Criteria:

* Patients \<18 years old, patients who have severe IDA that requires blood transfusion or IV iron infusion, patients who have other known hemoglobinopathy (such as thalassemia or sickle cell anemia) or anemia of different mechanism (such as vitamin B12 or folate deficiency), patients with ulcerative colitis, Crohn's disease, gastric ulcers, patients who have previously undergone gastric bypass surgery, patients who experience admission for antepartum bleed, have been diagnosed with abnormal placentation (i.e., placenta previa, placenta accreta, placenta increta or percreta)

Where it's running

  • Southern Illinois University School of Medicine
    Springfield, Illinois, United States
    Recruiting

Study contacts

  • Principal investigator: Yahia Zeino, MD — Southern Illinois University School of Medicine
  • Study coordinator: Kathleen A Groesch, MS
  • Email: kgroesch@siumed.edu
  • Phone: 217-545-6671

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.